(Rye Brook, NY, October 10, 2018) –The Leukemia & Lymphoma Society (LLS) continues to lead cutting-edge research to advance treatments for myeloma and lymphoma. Adding to the momentum, the organization today announced a $1,175,000 commitment by the Schwartz Ward Family Foundation (SWFF) of Chicago to support two unique research initiatives including a novel therapy for a rare form of lymphoma and an innovative ...
RULE COULD RESULT IN COMPREHENSIVE COVERAGE FOR PATIENTS BECOMING UNAFFORDABLE; LEAVE MANY UNCOVERED Patient groups representing millions of Americans with serious health conditions filed an amicus curiae (or friend-of-the-court) brief today in the U.S. District Court case, Association for Community Affiliated Plans v. United States, explaining the devastating impact patients could face under the fi...
Washington, D.C. (September 26, 2018) – The Leukemia & Lymphoma Society (LLS) commends the U.S. House of Representatives for approving a funding package today that will provide much-needed additional resources for federal cancer research efforts. The U.S. Senate passed this funding agreement with strong bipartisan support last week. The legislation now heads to the White House to be signed into law. “...
Rye Brook, NY, (September 25,2018) - As The Leukemia & Lymphoma Society’s (LLS) Light The Night fundraising campaign continues to beat growth records, leading national companies and brands are signing on to help light the path to cancer cures and give hope to cancer patients nationwide. Light The Night brings light to the darkness of cancer through 140 inspirational evening walks across the US and Canada each f...
Have media inquiries? Contact us between 9 a.m. and 5 p.m. ET, Monday through Friday: